Florian Märkl
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Chemokine receptors and signaling
-
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
Papers in
- Oncology 15
- CAR-T cell therapy research 12
- Cancer Immunotherapy and Biomarkers 4
- Chemokine receptors and signaling 1
-
- Immunotherapy and Immune Responses 2
- Immune Cell Function and Interaction 1
- T-cell and B-cell Immunology 1
- Co-authors
- Sebastian Kobold (6 shared papers)Stefan Endres (4 shared papers)Lisa Rohrbacher (2 shared papers)Veit Bücklein (2 shared papers)Stefanos Michaelides (1 shared paper)Tobias F. Feuchtinger (1 shared paper)Karsten Spiekermann (1 shared paper)John R. James (1 shared paper)
- Journals
- Blood (2 papers)British Journal of Cancer (2 papers)Cancer Immunology Immunotherapy (2 papers)Blood Advances (1 paper)Trends in cancer (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Florian Märkl
15 papers receiving 475 citations
Peers
Comparison fields: 5 of 40
- Oncology 329
- Immunology 85
- Physiology 17
- Hematology 25
- Genetics 8
Countries citing papers authored by Florian Märkl
This map shows the geographic impact of Florian Märkl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Märkl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Märkl more than expected).
Fields of papers citing papers by Florian Märkl
This network shows the impact of papers produced by Florian Märkl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Märkl. The network helps show where Florian Märkl may publish in the future.
Co-authors
The 25 scholars most cited alongside Florian Märkl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 129 | |
| 2 | 2021 | 94 | |
| 3 | 2023 | 87 | |
| 4 | 2023 | 71 | |
| 5 | 2022 | 35 | |
| 6 | 2022 | 15 | |
| 7 | 2023 | 15 | |
| 8 | 2024 | 12 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 8 | |
| 11 | 2024 | 4 | |
| 12 | 2022 | 2 | |
| 13 | 2025 | 2 | |
| 14 | 2025 | 2 | |
| 15 | 2022 | 1 |
About Florian Märkl
Florian Märkl is a scholar working on Oncology, Immunology, Physiology, Hematology and Pathology and Forensic Medicine, having authored 15 papers that have together received 485 indexed citations. Recurring topics across this work include CAR-T cell therapy research (12 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Acute Myeloid Leukemia Research (1 paper), Immune Cell Function and Interaction (1 paper), T-cell and B-cell Immunology (1 paper) and Chemokine receptors and signaling (1 paper). The work is most often cited by research in Oncology (329 citations), Immunology (85 citations), Physiology (17 citations), Hematology (25 citations) and Genetics (8 citations). Florian Märkl has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Sebastian Kobold, Stefan Endres, Lisa Rohrbacher, Veit Bücklein, Stefanos Michaelides, Tobias F. Feuchtinger, Karsten Spiekermann, John R. James, Bruno Loureiro Cadilha and Anetta Marcinek. Their work appears in journals such as Blood, British Journal of Cancer, Cancer Immunology Immunotherapy, Blood Advances and Trends in cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.